{
  "table_name": "quant_phosphoproteome_AML_ex_vivo_drug_response_primary_cohort_pdc_current",
  "table_fullname": "isb-cgc-bq.CPTAC.quant_phosphoproteome_AML_ex_vivo_drug_response_primary_cohort_pdc_current",
  "column_names": [
    "id_de_cas",
    "id_d_echantillon",
    "id_d_aliquote",
    "id_de_soumission_d_aliquote",
    "id_de_metadonnees_d_execution_d_aliquote",
    "nom_d_etude",
    "abondance_de_proteine_log2ratio",
    "id_refseq",
    "sites_de_phosphorylation"
  ],
  "column_types": [
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "FLOAT64",
    "STRING",
    "STRING"
  ],
  "nested_column_names": [
    "id_de_cas",
    "id_d_echantillon",
    "id_d_aliquote",
    "id_de_soumission_d_aliquote",
    "id_de_metadonnees_d_execution_d_aliquote",
    "nom_d_etude",
    "abondance_de_proteine_log2ratio",
    "id_refseq",
    "sites_de_phosphorylation"
  ],
  "nested_column_types": [
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "FLOAT64",
    "STRING",
    "STRING"
  ],
  "description": [
    "Identifiant unique associé à un patient spécifique (e.g. 24cb0fcb-63d6-11e8-bcf1-0a2705229b82)",
    "Identifiant PDC unique pour cet échantillon (e.g. e8d83eb9-693a-11ea-b1fd-0aad30af8a83)",
    "Identifiant PDC unique pour cet aliquot (e.g. e8db124a-693a-11ea-b1fd-0aad30af8a83)",
    "ID de soumission d'aliquot attribué par le programme (e.g. T14)",
    "Identifie de manière unique l'aliquot en fonction de son utilisation dans l'expérience (en fonction du réactif d'étiquetage et/ou de la répétition biologique)",
    "Nom de l'étude (e.g. Étude pilote sur le cancer du cerveau pédiatrique - Phosphoprotéome)",
    "Rapport log-moyen des ions rapporteurs d'échantillon par rapport à la référence commune des ions de peptides associés au gène dans les acquisitions d'un échantillon biologique spécifique",
    "Identifiant unique donné à une séquence dans la base de données NCBI RefSeq",
    "Codes à lettre unique et positions de séquence de protéine des acides aminés phosphorylés (e.g. t304s310, t59)"
  ],
  "sample_rows": [
    {
      "id_de_cas": "1411a35b-1847-4d87-b57f-993dfb9659f8",
      "id_d_echantillon": "cb883da7-73ff-40b2-8c82-01c85506d538",
      "id_d_aliquote": "597258f0-ff16-45a3-854e-45aa2b1d747b",
      "id_de_soumission_d_aliquote": "15-00051-1",
      "id_de_metadonnees_d_execution_d_aliquote": "695a16a9-027b-43c8-86c9-f5538b778a6f",
      "nom_d_etude": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
      "abondance_de_proteine_log2ratio": -1.8348,
      "id_refseq": "NP_000601.3",
      "sites_de_phosphorylation": "s706"
    },
    {
      "id_de_cas": "1411a35b-1847-4d87-b57f-993dfb9659f8",
      "id_d_echantillon": "cb883da7-73ff-40b2-8c82-01c85506d538",
      "id_d_aliquote": "597258f0-ff16-45a3-854e-45aa2b1d747b",
      "id_de_soumission_d_aliquote": "15-00051-1",
      "id_de_metadonnees_d_execution_d_aliquote": "695a16a9-027b-43c8-86c9-f5538b778a6f",
      "nom_d_etude": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
      "abondance_de_proteine_log2ratio": -1.1584,
      "id_refseq": "NP_001005.1",
      "sites_de_phosphorylation": "s146"
    },
    {
      "id_de_cas": "1411a35b-1847-4d87-b57f-993dfb9659f8",
      "id_d_echantillon": "cb883da7-73ff-40b2-8c82-01c85506d538",
      "id_d_aliquote": "597258f0-ff16-45a3-854e-45aa2b1d747b",
      "id_de_soumission_d_aliquote": "15-00051-1",
      "id_de_metadonnees_d_execution_d_aliquote": "695a16a9-027b-43c8-86c9-f5538b778a6f",
      "nom_d_etude": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
      "abondance_de_proteine_log2ratio": -1.3186,
      "id_refseq": "NP_001011553.2",
      "sites_de_phosphorylation": "t227"
    },
    {
      "id_de_cas": "1411a35b-1847-4d87-b57f-993dfb9659f8",
      "id_d_echantillon": "cb883da7-73ff-40b2-8c82-01c85506d538",
      "id_d_aliquote": "597258f0-ff16-45a3-854e-45aa2b1d747b",
      "id_de_soumission_d_aliquote": "15-00051-1",
      "id_de_metadonnees_d_execution_d_aliquote": "695a16a9-027b-43c8-86c9-f5538b778a6f",
      "nom_d_etude": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
      "abondance_de_proteine_log2ratio": -2.225,
      "id_refseq": "NP_001014972.1",
      "sites_de_phosphorylation": "s1401"
    },
    {
      "id_de_cas": "1411a35b-1847-4d87-b57f-993dfb9659f8",
      "id_d_echantillon": "cb883da7-73ff-40b2-8c82-01c85506d538",
      "id_d_aliquote": "597258f0-ff16-45a3-854e-45aa2b1d747b",
      "id_de_soumission_d_aliquote": "15-00051-1",
      "id_de_metadonnees_d_execution_d_aliquote": "695a16a9-027b-43c8-86c9-f5538b778a6f",
      "nom_d_etude": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
      "abondance_de_proteine_log2ratio": -2.4866,
      "id_refseq": "NP_001025459.1",
      "sites_de_phosphorylation": "s351s355"
    }
  ]
}